Corrections:
Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
Metrics: PDF 1630 views | ?
1Institut Curie, Inserm U830, Paris Sciences et Lettres University Paris, 75248, France
2University College London, Cancer Institute, London, WC1E 6BT, United Kingdom
3University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA
4Inserm U1151-CNRS UMR 8253, Institut Necker Enfants-Malades, Paris, 75993, France
5Present address: Cancer Research Center of Toulouse, UMR1037, Toulouse, 31100, France
*These authors have contributed equally to this work
Published: April 27, 2018
This article has been corrected: The correct Grant Support information is given below:
GRANT SUPPORT
This work was supported by the Wellcome Trust Research Career Development fellowship 090090/Z/09/Z (to A. Hergovich); the BBSRC grant BB/I021248/1 (to A. Hergovich); the National Institute for Health Research University College London Hospitals Biomedical Research Centre; the Ministry of National Education of the Republic of Turkey (to R. Gundogdu); the Ligue Nationale contre le cancer (LNCC) grants RD14/75-80 (to J. Camonis) and RS14/75-54 (to M.C. Parrini); the Fondation ARC grant SFI20121205710 (to M.C. Parrini); the ARC grant SFI20111203931 (to J. Camonis); the ANR grant ANR-13-CESA-0010-001 (to P. Codogno); the Association Christelle Bouillot; INCA; and institutional INSERM and CNRS funding. Work was supported also by grant ANR-08-NLAN-0290-01 to J. Camonis.
Original article: Oncotarget. 2016; 7:44142-44160. DOI: https://doi.org/10.18632/oncotarget.9875.
![Creative Commons License](/images/80x15.png)
PII: 25335